These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 31255411)

  • 1. [Pathological and molecular features of malignancies underlined by BAF complexes inactivation].
    Le Quang M; Ranchère-Vince D; Le Loarer F
    Ann Pathol; 2019 Dec; 39(6):399-413. PubMed ID: 31255411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMARCB1-deficient Tumors of Childhood: A Practical Guide.
    Pawel BR
    Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SWI/SNF-deficient thoraco-pulmonary neoplasms.
    Sesboue C; Le Loarer F
    Semin Diagn Pathol; 2021 May; 38(3):183-194. PubMed ID: 33451916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas.
    Le Loarer F; Watson S; Pierron G; de Montpreville VT; Ballet S; Firmin N; Auguste A; Pissaloux D; Boyault S; Paindavoine S; Dechelotte PJ; Besse B; Vignaud JM; Brevet M; Fadel E; Richer W; Treilleux I; Masliah-Planchon J; Devouassoux-Shisheboran M; Zalcman G; Allory Y; Bourdeaut F; Thivolet-Bejui F; Ranchere-Vince D; Girard N; Lantuejoul S; Galateau-Sallé F; Coindre JM; Leary A; Delattre O; Blay JY; Tirode F
    Nat Genet; 2015 Oct; 47(10):1200-5. PubMed ID: 26343384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No small surprise - small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour.
    Foulkes WD; Clarke BA; Hasselblatt M; Majewski J; Albrecht S; McCluggage WG
    J Pathol; 2014 Jul; 233(3):209-14. PubMed ID: 24752781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
    Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
    Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type.
    Andrianteranagna M; Cyrta J; Masliah-Planchon J; Nemes K; Corsia A; Leruste A; Holdhof D; Kordes U; Orbach D; Corradini N; Entz-Werle N; Pierron G; Castex MP; Brouchet A; Weingertner N; Ranchère D; Fréneaux P; Delattre O; Bush J; Leary A; Frühwald MC; Schüller U; Servant N; Bourdeaut F
    J Pathol; 2021 Sep; 255(1):1-15. PubMed ID: 33999421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer Surveillance in Gorlin Syndrome and Rhabdoid Tumor Predisposition Syndrome.
    Foulkes WD; Kamihara J; Evans DGR; Brugières L; Bourdeaut F; Molenaar JJ; Walsh MF; Brodeur GM; Diller L
    Clin Cancer Res; 2017 Jun; 23(12):e62-e67. PubMed ID: 28620006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Claudin-4 expression distinguishes SWI/SNF complex-deficient undifferentiated carcinomas from sarcomas.
    Schaefer IM; Agaimy A; Fletcher CD; Hornick JL
    Mod Pathol; 2017 Apr; 30(4):539-548. PubMed ID: 28084340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms.
    Dermawan JK; Singer S; Tap WD; Nacev BA; Chi P; Wexler LH; Ortiz MV; Gounder M; Antonescu CR
    Mod Pathol; 2022 Dec; 35(12):1900-1909. PubMed ID: 36088476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor.
    Fahiminiya S; Witkowski L; Nadaf J; Carrot-Zhang J; Goudie C; Hasselblatt M; Johann P; Kool M; Lee RS; Gayden T; Roberts CW; Biegel JA; Jabado N; Majewski J; Foulkes WD
    Oncotarget; 2016 Jan; 7(2):1732-40. PubMed ID: 26646792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma.
    Kolin DL; Dong F; Baltay M; Lindeman N; MacConaill L; Nucci MR; Crum CP; Howitt BE
    Mod Pathol; 2018 Sep; 31(9):1442-1456. PubMed ID: 29700418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chromatin remodeling defects and cancer: the SWI/SNF example].
    Bourdeaut F; Bièche I
    Bull Cancer; 2012 Dec; 99(12):1133-40. PubMed ID: 23222069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas.
    Nambirajan A; Dutta R; Malik PS; Bubendorf L; Jain D
    Acta Cytol; 2021; 65(1):67-74. PubMed ID: 32854100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of SMARCB1 (INI1) and SMARCA4 (BRG1) in poorly differentiated endometrioid adenocarcinoma of the uterus: analysis of a series with emphasis on a novel SMARCA4-deficient dedifferentiated rhabdoid variant.
    Strehl JD; Wachter DL; Fiedler J; Heimerl E; Beckmann MW; Hartmann A; Agaimy A
    Ann Diagn Pathol; 2015 Aug; 19(4):198-202. PubMed ID: 25920939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SWI/SNF complex-deficient soft tissue neoplasms: An update.
    Schaefer IM; Hornick JL
    Semin Diagn Pathol; 2021 May; 38(3):222-231. PubMed ID: 32646614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SWI/SNF chromatin remodeling complexes and cancer.
    Biegel JA; Busse TM; Weissman BE
    Am J Med Genet C Semin Med Genet; 2014 Sep; 166C(3):350-66. PubMed ID: 25169151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 cases.
    Agaimy A; Thiel F; Hartmann A; Fukunaga M
    Ann Diagn Pathol; 2015 Oct; 19(5):283-7. PubMed ID: 26123103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2:
    Chan-Penebre E; Armstrong K; Drew A; Grassian AR; Feldman I; Knutson SK; Kuplast-Barr K; Roche M; Campbell J; Ho P; Copeland RA; Chesworth R; Smith JJ; Keilhack H; Ribich SA
    Mol Cancer Ther; 2017 May; 16(5):850-860. PubMed ID: 28292935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SWI/SNF-deficient undifferentiated malignancies: where to draw the line
    Tessier-Cloutier B; Kleinman CL; Foulkes WD
    J Pathol; 2022 Feb; 256(2):139-142. PubMed ID: 34767264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.